Dechra Pharmaceuticals (DPH)
Health Care Sector

  • Latest quote

    2,626.00p (mid)

  • Current Change (%)

    0.92%

  • Price

    Bid: 2,640.00p

    Offer: 2,642.00p

  • Today

    High: 2,650.00p

    Low: 2,606.00p

  • This year

    High: 3,036.00p

    Low: 2,014.00p

  • Information

    Volume: 313,746

    Market Cap: £2678.52M

NOTE: This is based on 34 open tips for this company


Total Number of Share tips :

52

View all Dechra Pharmaceuticals Tips




Dechra Pharmaceuticals Overview

Dechra Pharmaceuticals, founded in 1997 following a management buy-out from Lloyds Chemists, develops prescription only veterinary medicines for dogs, cats and horses. Most of its projects involve adapting treatments, currently used by humans, for the animal market. Expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. It listed in London in 2000.

Dechra Pharmaceuticals RNS Feed

Title Release date
Holding(s) in Company 15:42 - October 2, 2019
Total Voting Rights 09:49 - September 30, 2019
Director/PDMR Shareholding 16:50 - September 23, 2019
Director/PDMR Shareholdings 09:32 - September 18, 2019
Annual Financial Report 10:03 - September 17, 2019
Block listing Interim Review 14:15 - September 16, 2019
Opening of its solar power plant in Croatia & CMD 10:34 - September 11, 2019
Director/PDMR Shareholding 15:45 - September 6, 2019
Availability of the 2019 Annual Report 13:32 - September 4, 2019
Audited preliminary results - year ended 30.6.19 07:00 - September 2, 2019
Additional Listing 12:55 - August 30, 2019
Acquisition of Ampharmco LLC, USA 07:00 - August 29, 2019
LICENSING AGREEMENT FOR SIGNIFICANT NOVEL PRODUCT 07:30 - August 2, 2019
Trading Update & Notice of Results 07:00 - July 9, 2019
Holding(s) in Company 14:38 - July 5, 2019

Daily share tips delivered straight to your pc, tablet & mobile

Join Free Today